Prognostic significance of KIF23 expression in gastric cancer

Table 4 Correlation between KIF23 mRNA expression and gastric cancer patients in Kaplan–Meier database

Variable	Cases	HR (95%CI)	P value
Overall patients	593	1.64 (1.32-2.02)	3.9e-061
T stage
T2	66	2.05 (0.98-4.26)	0.0501
T3	117	1.83 (1.14-2.94)	0.0121
N stage
N0	38	2.78 (0.88-8.73)	0.069
N1 + N2 + N3	175	1.33 (0.92-1.94)	0.130
M stage
M0	186	1.74 (1.17-2.59)	0.00531
M1	31	0.49 (0.19-1.23)	0.120
Gender
Male	360	2.07 (1.60-2.69)	1.9e-081
Female	138	1.50 (0.95-2.37)	0.078
Differentiation
Well	32	0.41 (0.16-1.08)	0.062
Moderate	67	0.75 (0.38-1.48)	0.400
Poor	165	1.67 (1.12-2.49)	0.0121
Lauren classification
GITA	179	0.76 (0.52-1.11)	0.15
GDA	106	2.05 (1.23-3.39)	0.00471
GMA	25	0.22 (0.03-1.68)	0.11

¹Significant difference.